Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
1999 ◽
Vol 354
(9194)
◽
pp. 1932-1939
◽
1994 ◽
Vol 344
(8930)
◽
pp. 1105-1110
◽
2018 ◽
Vol 47
(4)
◽
pp. 276-281
◽
2009 ◽
Vol 30
(7)
◽
pp. 977-978
◽
2015 ◽
Vol 75
(10)
◽
pp. 1757-1762
◽
2019 ◽
Vol 44
(3)
◽
pp. 269-276
◽